At Genmab, our colleagues are passionate about making an impact on patients’ lives. With the opportunity to build new and bold futures, our colleagues embody the spirit of extra[not]ordinary®. This is our unique word, meaning we go way beyond what is usual—to be remarkable, proudly unique, and authentic. Hear from Melissa Rizzo, Manager, Field Operations on her experience working at Genmab. To #JoinGenmab, visit: http://gmab.ly/QCBu50SWQy2. #ExtraNotOrdinary
Over ons
We are an international biotech company committed to our goal of improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, our passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative, and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector function enhanced antibodies. By 2030, our vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO®) antibody medicines. We are united by our core values: a passion for innovation, determination, integrity, and working as one team and respecting each other. When you work at Genmab you'll be part of a warm, fun, dynamic community seeking out and embracing the opportunity to build new and bold futures within a rapidly growing biotechnology company. Genmab is a place where you can be authentically you; you are empowered to innovate, build solutions and execute; you feel cared for and supported. In its totality, this makes working at Genmab an extra[not]ordinaryTM experience. Established in 1999, we are headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com. Disclaimer: http://bit.ly/GENDisclaimer
- Website
-
http://www.genmab.com
Externe link voor Genmab
- Branche
- Biotechnologisch onderzoek
- Bedrijfsgrootte
- 1.001 - 5.000 medewerkers
- Hoofdkantoor
- Copenhagen V
- Type
- Naamloze vennootschap
Locaties
-
Primair
Kalvebod Brygge 43
Copenhagen V, DK-1560 , DK
-
777 Scudders Mill Rd
Plainsboro, NJ 08536, US
-
Uppsalalaan 15
Utrecht, CT 3584, NL
-
Level 21 Shiodome Shibarikyu Building
1-2-3 Kaigan
Minato-ku, Tokyo 105-0022, JP
Medewerkers van Genmab
-
Hinrich Göhlmann
Scientific Director specializing in 𝐇𝐢𝐠𝐡-𝐃𝐢𝐦𝐞𝐧𝐬𝐢𝐨𝐧𝐚𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 | Bridging Science, Data, and Technology
-
Amy D.
Director, Digital Products, Experience Management @ Genmab | Digital Transformation | ex-Amex | ex-Regeneron
-
Javier Pintado
Vice President, Global Marketing at Genmab
-
Caroline Eilering
Updates
-
As we continue our journey to become a biotech innovation powerhouse, this week marks one year since Genmab opened its new headquarters. This new space in Valby, Copenhagen was designed to support our culture of innovation and collaboration. Learn more about opportunities to be a part of our team: http://gmab.ly/2MzC50SW2YG. #Biotech #Innovation
-
Putting #PatientsFirst means prioritizing patients’ needs in every aspect of our work. Hear from Keshia Carpenter, Clinical Trial Manager, as she shares how her experience as a cancer patient shapes her daily work at Genmab. Learn more about patient engagement at Genmab: http://gmab.ly/hxwV50SW32c. #InspiredByPatients
-
#InvestorUpdate: Genmab has published its Interim Report for the first half of 2024. Executive Vice President and Chief Financial Officer Anthony Pagano shares how we’re strengthening our mid-to-late pipeline of innovative antibody products to propel towards our vision of transforming the lives of people with cancer and other serious diseases. To read the report, visit: http://gmab.ly/elgM50SU4Jk. #Biotech #Innovation
-
-
#InvestorUpdate: Join us for our 2024 Interim Report for the first half of the year. To register for the event, visit: http://gmab.ly/cJU450SL2tV. #Biotech #Innovation
-
-
At Genmab, our purpose of improving the lives of patients through innovative and differentiated antibody therapeutics brings us together. We believe in creating a culture where colleagues belong to something bigger than themselves. If you are interested in learning more about becoming a part of our team, check out our new careers page at the link below, where we share colleagues' stories, extra[not]ordinary® testimonials and open positions. http://gmab.ly/a9y950SLgsY
-
In honor of #NationalInternDay, we thank our bright summer interns for their contributions and dedication to advancing science and bringing antibody medicines to patients in need. It is a great time to reflect on our personal journeys and never forget where we started. Best of luck to all the interns who are doing their best to advance their career and pave the path to their future. We encourage our colleagues and followers to share memories from your internship experiences. #internship
-
Thank you for following along with us on our journey to advance antibody science and innovation to improve the lives of patients. On this milestone of reaching 100,000 followers, we want to thank you for following us and encourage you to subscribe to our newsletter: http://gmab.ly/t8Lt50SCGNV.
-
At Genmab, our passion for innovation drives everything we do - from discovering and developing next-gen antibodies to delivering innovative antibody therapeutics to patients. The Annual Genmab Innovation Tournament, now in its 5th year, harnesses our collective creativity to spark new ideas, technologies, and product concepts. This year, we received a record-breaking number of submissions from our colleagues, showcasing how AI and digitalization are transforming our daily work. Congratulations to all the winners and participants! Learn more about our innovative approach: https://bit.ly/3XuqD4t. #AntibodyScience #Innovation
-
Welcome to Genmab’s July Edition of Knock-Your-Socks-Off-News, a monthly newsletter covering our current happenings across the globe. Follow along with us on our journey for more updates as we advance innovation and continue to work towards our goal of transforming the lives of patients through antibody medicines. #culture #news #healthcare
Vergelijkbare pagina’s
Door vacatures bladeren
Financiering
Laatste ronde
Vermogen na beursgangUS$ 134.000.000,00